KAINOS Laboratories, Inc. (TYO:4556)
1,196.00
+61.00 (5.37%)
Apr 25, 2025, 9:06 AM JST
KAINOS Laboratories Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 |
---|---|---|---|---|---|---|
Period Ending | Dec '10 Dec 31, 2010 | Mar '10 Mar 31, 2010 | Mar '09 Mar 31, 2009 | Mar '08 Mar 31, 2008 | Mar '07 Mar 31, 2007 | Mar '06 Mar 31, 2006 |
Cash & Equivalents | 692.91 | 563.75 | 708.14 | 441.53 | 453.64 | 572.16 |
Short-Term Investments | 340 | 340 | 340 | 130 | 130 | 130 |
Cash & Short-Term Investments | 1,033 | 903.75 | 1,048 | 571.53 | 583.64 | 702.16 |
Cash Growth | -6.32% | -13.78% | 83.39% | -2.08% | -16.88% | - |
Accounts Receivable | 1,001 | 881.43 | 744.49 | 760.35 | 910.13 | 793 |
Other Receivables | - | - | - | - | - | 13.58 |
Receivables | 1,001 | 1,029 | 844.82 | 830.19 | 910.13 | 1,065 |
Inventory | 325.77 | 313.61 | 305.17 | 468.4 | 477.93 | 496.3 |
Prepaid Expenses | - | 15.39 | 13.02 | 11.03 | 8.94 | 8.29 |
Other Current Assets | 51.93 | 15.49 | 20.4 | 29.39 | 71.56 | 39.7 |
Total Current Assets | 2,412 | 2,322 | 2,261 | 1,935 | 2,091 | 2,367 |
Property, Plant & Equipment | 2,805 | 2,812 | 2,837 | 2,898 | 2,989 | 2,822 |
Long-Term Investments | 422.85 | 208.66 | 192.5 | 227.26 | 257.51 | 237.37 |
Other Intangible Assets | 84.26 | 77.19 | 105.87 | 139.89 | 90.35 | 25.72 |
Long-Term Deferred Tax Assets | - | 21.29 | 28.74 | 25.49 | 12.82 | 7.81 |
Other Long-Term Assets | 0 | 235.3 | 149.35 | 146.61 | 147.62 | 179.02 |
Total Assets | 5,724 | 5,677 | 5,575 | 5,372 | 5,588 | 5,639 |
Accounts Payable | 795.93 | 976.4 | 815.65 | 761.79 | 847.17 | 951.52 |
Accrued Expenses | 31 | 101.16 | 57.9 | 36.92 | 37.45 | 73.39 |
Short-Term Debt | 1,249 | 860 | 710 | 710 | 466 | 420.05 |
Current Portion of Long-Term Debt | - | 242.85 | 475.46 | 499.03 | 749.21 | 380.03 |
Current Portion of Leases | - | 6.79 | 2.39 | - | - | - |
Current Income Taxes Payable | 8.54 | 45.93 | 110.33 | 8.13 | 3.39 | 157.29 |
Other Current Liabilities | 281.77 | 6.32 | 5.93 | 7.44 | 7.84 | 84.21 |
Total Current Liabilities | 2,366 | 2,239 | 2,178 | 2,023 | 2,111 | 2,066 |
Long-Term Debt | 549.11 | 688.66 | 745.71 | 859.87 | 933.04 | 1,003 |
Long-Term Leases | - | 14.24 | 7.46 | - | - | - |
Other Long-Term Liabilities | 124.6 | 76.7 | 78.1 | 82.89 | 87.39 | 88.38 |
Total Liabilities | 3,040 | 3,019 | 3,009 | 2,966 | 3,131 | 3,158 |
Common Stock | 831.41 | 831.41 | 831.41 | 831.41 | 831.41 | 831.41 |
Additional Paid-In Capital | 928.73 | 928.73 | 928.73 | 928.73 | 928.73 | 928.73 |
Retained Earnings | 1,007 | 979.47 | 895.84 | 728.12 | 757.41 | 775.75 |
Treasury Stock | -89.91 | -89.74 | -88.91 | -88.82 | -87.97 | -87.61 |
Comprehensive Income & Other | 7.48 | 8.47 | -1.22 | 6.43 | 26.94 | 32.8 |
Shareholders' Equity | 2,684 | 2,658 | 2,566 | 2,406 | 2,457 | 2,481 |
Total Liabilities & Equity | 5,724 | 5,677 | 5,575 | 5,372 | 5,588 | 5,639 |
Total Debt | 1,798 | 1,813 | 1,941 | 2,069 | 2,148 | 1,803 |
Net Cash (Debt) | -764.9 | -908.8 | -892.88 | -1,497 | -1,565 | -1,101 |
Net Cash Per Share | -171.76 | -204.02 | -200.39 | -335.92 | -350.91 | -246.87 |
Filing Date Shares Outstanding | 4.45 | 4.45 | 4.46 | 4.46 | 4.46 | 4.46 |
Total Common Shares Outstanding | 4.45 | 4.45 | 4.46 | 4.46 | 4.46 | 4.46 |
Working Capital | 46.08 | 83.05 | 83.19 | -88.46 | -19.86 | 300.44 |
Book Value Per Share | 602.71 | 596.89 | 575.84 | 539.94 | 550.93 | 556.38 |
Tangible Book Value | 2,600 | 2,581 | 2,460 | 2,266 | 2,366 | 2,455 |
Tangible Book Value Per Share | 583.79 | 579.56 | 552.08 | 508.54 | 530.67 | 550.61 |
Land | 1,851 | 1,851 | 1,851 | 1,851 | 1,851 | 1,851 |
Buildings | - | 1,971 | 1,966 | 1,962 | 1,962 | 1,710 |
Machinery | - | 531.54 | 516.76 | 463.54 | 433.01 | 541.25 |
Construction In Progress | - | - | - | - | - | 13.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.